Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.3M Buy
98,852
+3,841
+4% +$796K 0.69% 48
2026
Q1
$21.3M Buy
95,011
+2,589
+3% +$645K 0.84% 42
2025
Q4
$22.3M Buy
92,422
+30
+0% +$7.67K 0.86% 42
2025
Q3
$25.3M Sell
92,392
-3,144
-3% -$859K 1.01% 33
2025
Q2
$24.6M Buy
95,536
+1,526
+2% +$364K 1.06% 29
2025
Q1
$21M Buy
94,010
+961
+1% +$224K 0.99% 31
2024
Q4
$21.3M Sell
93,049
-117
-0.1% -$28.2K 0.97% 30
2024
Q3
$22.7M Sell
93,166
-5,942
-6% -$1.33M 1.05% 24
2024
Q2
$19M Sell
99,108
-468
-0.5% -$95K 0.92% 30
2024
Q1
$19.7M Buy
99,576
+376
+0.4% +$68.9K 0.96% 29
2023
Q4
$17.1M Buy
99,200
+3,401
+4% +$523K 0.89% 33
2023
Q3
$14.2M Buy
95,799
+73,324
+326% +$13.3M 0.8% 37
2023
Q2
$4.91M Buy
+22,475
New +$5.01M 0.26% 82
2022
Q4
$4.36K Buy
20,960
+2,148
+11% +$472K ﹤0.01% 317
2022
Q3
$3.94M Hold
18,812
0.26% 78
2022
Q2
$3.94M Buy
18,812
+390
+2% +$83K 0.26% 78
2022
Q1
$4.47M Buy
18,422
+1,345
+8% +$325K 0.25% 77
2021
Q4
$4.45M Buy
17,077
+2,440
+17% +$633K 0.24% 79
2021
Q3
$3.86M Buy
14,637
+40
+0.3% +$10.9K 0.24% 77
2021
Q2
$3.6M Buy
14,597
+2,225
+18% +$468K 0.23% 75
2021
Q1
$2.4M Buy
12,372
+1,390
+13% +$279K 0.16% 85
2020
Q4
$2.33M Buy
10,982
+635
+6% +$127K 0.17% 84
2020
Q3
$1.77M Buy
10,347
+1,625
+19% +$300K 0.14% 86
2020
Q2
$1.68M Buy
8,722
+1,965
+29% +$321K 0.15% 88
2020
Q1
$995K Buy
+6,757
New +$1.08M 0.1% 107

Other funds holding RMD

D.J. St. Germain's RMD Position: Q2 2026 in Review

D.J. St. Germain increased its ResMed (RMD) stake by 4% in Q2 2026, buying an estimated $796K and bringing the position to 98,852 shares worth $19.3M. The position accounts for 0.69% of the portfolio, ranked #48.

D.J. St. Germain first reported a position in RMD in Q1 2020 and has held it in 25 quarters since. The position peaked at $25.3M in Q3 2025. 137 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • D.J. St. Germain held 98,852 shares of ResMed worth $19.3M as of Q2 2026.
  • D.J. St. Germain bought 3,841 ResMed shares in Q2 2026, an estimated $796K.
  • ResMed made up 0.69% of D.J. St. Germain's portfolio in Q2 2026, its #48 holding.
  • D.J. St. Germain first reported a position in ResMed in Q1 2020 and has held it in 25 quarters since.
  • D.J. St. Germain's ResMed position peaked at $25.3M in Q3 2025.
  • 137 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.